首页> 外文期刊>Journal of laparoendoscopic and advanced surgical techniques, Part A >Transperitoneal Intravesical Technique for Laparoscopic Ureteral Reimplantation to Treat Terminal Ureteral Stenosis
【24h】

Transperitoneal Intravesical Technique for Laparoscopic Ureteral Reimplantation to Treat Terminal Ureteral Stenosis

机译:腹腔镜输尿管再抑制治疗末端输尿管狭窄的细胞肌瘤膀胱内技术

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To describe a newly developed transperitoneal intravesical technique for laparoscopic ureteral reimplantation in patients with terminal ureteral stenosis. Methods: Between July 2009 and May 2015, laparoscopic transperitoneal intravesical ureteral reimplantation was performed in 16 patients with terminal ureteral stenosis without vesicoureteral reflux (VUR). An incision was made in the superior bladder wall of the affected side with an electric hook. The bladder mucosa was then circumferentially cut away from the ureteral orifice to a distance of 0.5cm, and the intramural portion of the ureter was freed from the bladder wall and dissected until 4 to 5cm of terminal ureter was mobilized. The stenotic segment was resected, and a longitudinal cut was made in the mobilized ureter. The terminal ureter was then evaginated and sutured to the bladder wall to form a papilla. All patients underwent standard postoperative examinations. Results: All of the 16 operations were successful, and none required conversion to an extravesical approach or open surgery. The operation time ranged from 85 to 135 minutes (mean 98 minutes), and the estimated blood loss was approximate to 30-60mL (mean 42mL). There were no obvious intraoperative or postoperative complications. Resolution of hydronephrosis was achieved in all 16 patients, and VUR of the operated ureter was not detected at postoperative follow-up. Conclusions: The transperitoneal intravesical technique of laparoscopic ureteral reimplantation that we describe was safe and feasible in our 16 patients and may be an alternative surgical treatment for terminal ureteral stenosis in patients without VUR.
机译:目的:描述患有终端输尿管狭窄患者的腹腔镜输尿管再抑制的新开发的翻剖膀胱内技术。方法:2009年7月至2015年5月,腹腔镜体细胞瘤性膀胱内部输尿管再抑制在16例患有症患者的患者狭窄的患者中进行,没有脓疱管反流(VUR)。用电动钩在受影响的侧面的上膀胱壁上进行切口。然后将膀胱粘膜从输尿管孔周长切断到0.5cm的距离,并且从膀胱壁上释放出尿道的牙腔内部分,并溶解在4至5cm的末端输注中。切除狭窄的细分,并在动员的输尿管中进行纵向切割。然后将末端输尿管进行了迁移和缝合到膀胱壁上以形成乳头。所有患者均接受标准术后检查。结果:16个操作中的所有操作都是成功的,没有必要转换为外部方法或公开手术。操作时间为85至135分钟(平均98分钟),估计的血液损失近似为30-60ml(平均42ml)。没有明显的术中或术后并发症。在所有16名患者中达到了肾内鼻的分辨率,并且在术后随访中未检测到操作的输尿管的VUR。结论:在我们的16名患者中,我们描述的腹腔镜输尿管内术治疗的翻剖膀胱内膀胱内技术是安全可行的,并且可能是没有VUR患者患者末端输尿管狭窄的替代手术治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号